GlassScriptPhysician profile
Laura Tatpati
NPI 1073584728
$1,130.39
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $211 · 2021: $165 · 2022: $193 · 2023: $192 · 2024: $16.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $322.34 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $224.83 | 2019-2022 | |
| Medtronic, INC. | $174.14 | 2021-2023 | Truclear |
| Myovant Sciences INC. | $128.01 | 2021-2022 | |
| Davol INC. | $101.04 | 2023 | |
| Emd Serono, INC. | $94.06 | 2019-2024 | |
| Hologic Sales and Service, LLC | $24.96 | 2019-2021 | |
| Therapeuticsmd, INC. | $18.79 | 2019 | |
| Sumitomo Pharma America, INC. | $16.07 | 2023 | Myfembree |
| Olympus America INC. | $14.19 | 2020 | |
| Duchesnay USA Incorporated | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Tatpati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.